Proteomics Reveals mRNA Regulation and the Action of Annexins in Thyroid Cancer

Differentiated thyroid cancer is the most common malignancy of the endocrine system. Although most thyroid nodules are benign, given the high incidence of thyroid nodules in the population, it is important to understand the differences between benign and malignant thyroid cancer and the molecular al...

Full description

Bibliographic Details
Main Authors: Margarida Coelho, João Capela, Sandra I. Anjo, João Pacheco, Margarida Sá Fernandes, Isabel Amendoeira, John G. Jones, Luís Raposo, Bruno Manadas
Format: Article
Language:English
Published: MDPI AG 2023-09-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/24/19/14542
_version_ 1797575850011394048
author Margarida Coelho
João Capela
Sandra I. Anjo
João Pacheco
Margarida Sá Fernandes
Isabel Amendoeira
John G. Jones
Luís Raposo
Bruno Manadas
author_facet Margarida Coelho
João Capela
Sandra I. Anjo
João Pacheco
Margarida Sá Fernandes
Isabel Amendoeira
John G. Jones
Luís Raposo
Bruno Manadas
author_sort Margarida Coelho
collection DOAJ
description Differentiated thyroid cancer is the most common malignancy of the endocrine system. Although most thyroid nodules are benign, given the high incidence of thyroid nodules in the population, it is important to understand the differences between benign and malignant thyroid cancer and the molecular alterations associated with malignancy to improve detection and signal potential diagnostic, prognostic, and therapeutic targets. Proteomics analysis of benign and malignant human thyroid tissue largely revealed changes indicating modifications in RNA regulation, a common cancer characteristic. In addition, changes in the immune system and cell membrane/endocytic processes were also suggested to be involved. Annexin A1 was considered a potential malignancy biomarker and, similarly to other annexins, it was found to increase in the malignant group. Furthermore, a bioinformatics approach points to the transcription factor Sp1 as being potentially involved in most of the alterations seen in the malignant thyroid nodules.
first_indexed 2024-03-10T21:44:07Z
format Article
id doaj.art-dc46729911d845778221c331eb3c22d2
institution Directory Open Access Journal
issn 1661-6596
1422-0067
language English
last_indexed 2024-03-10T21:44:07Z
publishDate 2023-09-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-dc46729911d845778221c331eb3c22d22023-11-19T14:28:08ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672023-09-0124191454210.3390/ijms241914542Proteomics Reveals mRNA Regulation and the Action of Annexins in Thyroid CancerMargarida Coelho0João Capela1Sandra I. Anjo2João Pacheco3Margarida Sá Fernandes4Isabel Amendoeira5John G. Jones6Luís Raposo7Bruno Manadas8CNC—Center for Neurosciences and Cell Biology, University of Coimbra, 3004-517 Coimbra, PortugalCentro Hospitalar Universitário São João, 4200-319 Porto, PortugalCNC—Center for Neurosciences and Cell Biology, University of Coimbra, 3004-517 Coimbra, PortugalCentro Hospitalar Universitário São João, 4200-319 Porto, PortugalCentro Hospitalar Universitário São João, 4200-319 Porto, PortugalCentro Hospitalar Universitário São João, 4200-319 Porto, PortugalCNC—Center for Neurosciences and Cell Biology, University of Coimbra, 3004-517 Coimbra, PortugalPortuguese Society of Endocrinology, Diabetes and Metabolism, 1600-892 Lisbon, PortugalCNC—Center for Neurosciences and Cell Biology, University of Coimbra, 3004-517 Coimbra, PortugalDifferentiated thyroid cancer is the most common malignancy of the endocrine system. Although most thyroid nodules are benign, given the high incidence of thyroid nodules in the population, it is important to understand the differences between benign and malignant thyroid cancer and the molecular alterations associated with malignancy to improve detection and signal potential diagnostic, prognostic, and therapeutic targets. Proteomics analysis of benign and malignant human thyroid tissue largely revealed changes indicating modifications in RNA regulation, a common cancer characteristic. In addition, changes in the immune system and cell membrane/endocytic processes were also suggested to be involved. Annexin A1 was considered a potential malignancy biomarker and, similarly to other annexins, it was found to increase in the malignant group. Furthermore, a bioinformatics approach points to the transcription factor Sp1 as being potentially involved in most of the alterations seen in the malignant thyroid nodules.https://www.mdpi.com/1422-0067/24/19/14542proteomicsscreeningthyroid cancerannexinsSp1
spellingShingle Margarida Coelho
João Capela
Sandra I. Anjo
João Pacheco
Margarida Sá Fernandes
Isabel Amendoeira
John G. Jones
Luís Raposo
Bruno Manadas
Proteomics Reveals mRNA Regulation and the Action of Annexins in Thyroid Cancer
International Journal of Molecular Sciences
proteomics
screening
thyroid cancer
annexins
Sp1
title Proteomics Reveals mRNA Regulation and the Action of Annexins in Thyroid Cancer
title_full Proteomics Reveals mRNA Regulation and the Action of Annexins in Thyroid Cancer
title_fullStr Proteomics Reveals mRNA Regulation and the Action of Annexins in Thyroid Cancer
title_full_unstemmed Proteomics Reveals mRNA Regulation and the Action of Annexins in Thyroid Cancer
title_short Proteomics Reveals mRNA Regulation and the Action of Annexins in Thyroid Cancer
title_sort proteomics reveals mrna regulation and the action of annexins in thyroid cancer
topic proteomics
screening
thyroid cancer
annexins
Sp1
url https://www.mdpi.com/1422-0067/24/19/14542
work_keys_str_mv AT margaridacoelho proteomicsrevealsmrnaregulationandtheactionofannexinsinthyroidcancer
AT joaocapela proteomicsrevealsmrnaregulationandtheactionofannexinsinthyroidcancer
AT sandraianjo proteomicsrevealsmrnaregulationandtheactionofannexinsinthyroidcancer
AT joaopacheco proteomicsrevealsmrnaregulationandtheactionofannexinsinthyroidcancer
AT margaridasafernandes proteomicsrevealsmrnaregulationandtheactionofannexinsinthyroidcancer
AT isabelamendoeira proteomicsrevealsmrnaregulationandtheactionofannexinsinthyroidcancer
AT johngjones proteomicsrevealsmrnaregulationandtheactionofannexinsinthyroidcancer
AT luisraposo proteomicsrevealsmrnaregulationandtheactionofannexinsinthyroidcancer
AT brunomanadas proteomicsrevealsmrnaregulationandtheactionofannexinsinthyroidcancer